In December 2004, Philip Morabito sued Pfizer and Henry A. McKinnell, then Pfizer's board chair and chief executive officer, alleging two claims under the Securities and Exchange Act of 1934. In 2012, an amended complaint was filed that alleged that Pfizer and the individual defendants had made false representations and omissions regarding the cardiovascular risks associated with two of Pfizer's drugs: Celebrex and Bextra. (Photo: Daniel Acker/Bloomberg)
A Delaware court has ruled that exclusions in insurance policies issued to Pfizer Inc. did not preclude coverage for the $568 million it agreed to pay to settle a securities fraud class action.
Want to continue reading?
Become a Free PropertyCasualty360 Digital Reader
Your access to unlimited PropertyCasualty360 content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking insurance news and analysis, on-site and via our newsletters and custom alerts
- Weekly Insurance Speak podcast featuring exclusive interviews with industry leaders
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the employee benefits and financial advisory markets on our other ALM sites, BenefitsPRO and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Steven A. Meyerowitz
Steven A. Meyerowitz, a Harvard Law School graduate, is the founder and president of Meyerowitz Communications Inc., a law firm marketing communications consulting company. He may be contacted at [email protected].
